NYSE:MDT Stock Quote
87.67
-0.61 (-0.69%)
Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients
The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world.
Via The Motley Fool · March 28, 2025
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.
Via Investor's Business Daily · March 27, 2025
China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, with Vice Premier He Lifeng promising a better business environment amid rising U.S. tariff pressures and slowing foreign investment.
Via Benzinga · March 23, 2025

In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.
Via Investor's Business Daily · February 25, 2025

The medical device maker has been a huge winner for its long-term shareholders.
Via The Motley Fool · February 21, 2025
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT).
Via Chartmill · March 18, 2025
Via The Motley Fool · March 17, 2025

Via Benzinga · March 4, 2025

The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors.
Via Investor's Business Daily · February 18, 2025

MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.
Via Chartmill · February 27, 2025

Via The Motley Fool · February 24, 2025

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Via Benzinga · February 24, 2025

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news
Via MarketBeat · February 22, 2025

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.
Via MarketBeat · February 21, 2025

Via The Motley Fool · February 20, 2025

The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.
Via Stocktwits · February 18, 2025

MDT earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 18, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · February 18, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 18, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · February 18, 2025